Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M127Revenue $M1.0Net Margin (%)-6,930.4Altman Z-Score-9.0
Enterprise Value $M125EPS $-3.4Operating Margin %-6,720.9Piotroski F-Score1
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)-6,930.4Higher ROA y-yN
Price/Book26.810-y EBITDA Growth Rate %--Quick Ratio4.4Cash flow > EarningsY
Price/Sales1035-y EBITDA Growth Rate %--Current Ratio4.4Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-107.6Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-216.4Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M20.7ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with ARGS

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

ARGS is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


ARGS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Lamarre JeanDirector 2015-08-25Buy2,500$6.140.33 view
Winterbottom JoanChief Human Resources Officer 2015-08-24Buy1,000$6.10.98 view
Nicolette Charles A.Chief Scientific Officer 2015-08-20Buy5,000$6.45-4.5 view
Van Holle Philippe Marie MarceDirector 2015-08-20Buy8,100$5.3914.29 view
Abbey Jeffrey DCEO 2015-08-19Buy5,500$4.7529.68 view
Pharmstandard International S.10% Owner 2014-02-12Buy1,275,000$8-23 view
Underdown Brian J.Director, 10% Owner 2014-02-12Buy40,497$8-23 view
Cooperatieve AAC LS U.A.10% Owner 2014-02-12Buy36,416$8-23 view
Birner HubertDirector, 10% Owner 2014-02-12Buy39,873$8-23 view
van Deventer SanderDirector, 10% Owner 2014-02-12Buy36,416$8-23 view

Quarterly/Annual Reports about ARGS:

    News about ARGS:

    Articles On GuruFocus.com
    Investment Strategies for the Bullish Biotech Sector Jun 01 2015 
    Weekly 3-Year Low Highlights: VCRA, CLUB, ARGS, ONTX, BOTA Jun 08 2014 

    More From Other Websites
    ARGOS THERAPEUTICS INC Financials Aug 28 2015
    Argos Therapeutics Awarded Patent for Its Experimental Individualized Immunotherapy for the... Aug 24 2015
    Argos Therapeutics Awarded Patent for Its Experimental Individualized Immunotherapy for the... Aug 24 2015
    Argos Therapeutics (ARGS) Jumps: Stock Moves Up 12% Aug 21 2015
    Edited Transcript of ARGS earnings conference call or presentation 12-Aug-15 8:30pm GMT Aug 19 2015
    ARGOS THERAPEUTICS INC Files SEC form 10-Q, Quarterly Report Aug 14 2015
    Argos Therapeutics reports 2Q loss Aug 12 2015
    Argos Therapeutics reports 2Q loss Aug 12 2015
    Argos Therapeutics Reports Second Quarter 2015 Financial Results and Operational Highlights Aug 12 2015
    ARGOS THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Aug 12 2015
    Argos Therapeutics Reports Second Quarter 2015 Financial Results and Operational Highlights Aug 12 2015
    Q2 2015 Argos Therapeutics Inc Earnings Release - After Market Close Aug 12 2015
    Argos Therapeutics Announces Pilot Clinical Trial of AGS-003 as Neoadjuvant Immunotherapy for... Aug 10 2015
    Argos Therapeutics Announces Pilot Clinical Trial of AGS-003 as Neoadjuvant Immunotherapy for... Aug 10 2015
    Argos Therapeutics to Hold Second Quarter 2015 Financial Results Conference Call on Wednesday,... Aug 05 2015
    Argos Therapeutics to Hold Second Quarter 2015 Financial Results Conference Call on Wednesday,... Aug 05 2015
    Argos Therapeutics Announces Formation of Scientific Advisory Board Jul 21 2015
    Argos Therapeutics Announces Formation of Scientific Advisory Board Jul 21 2015
    Argos Therapeutics to Present at 8th IAS Conference on HIV Pathogenesis, Treatment and Prevention Jul 17 2015
    Argos Therapeutics to Present at 8th IAS Conference on HIV Pathogenesis, Treatment and Prevention Jul 17 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK